Job Description
At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
KNOWLEDGE AND SKILL:
Knowledge of engineering generally attained through studies resulting in a Bachelor of Science degree in engineering (mechanical, electrical or chemical engineering preferred).
A minimum of 6 years of experience in conceptual development, project management, planning and scheduling projects, including experience in the Biotech or related industry.
Knowledge and experience with regulatory requirements, engineering principles, and construction techniques is important.
Demonstrated proficiency communicating and collaborating at a variety of levels with customers, vendors, equipment suppliers and operations staff.
Experience in supporting manufacturing operations is desired.
Strong leadership and communication skills.
Proven success working well in a team environment with flexibility to react to changing business needs.
The candidate should also demonstrate core BMS behaviors, especially Accountability and Urgency.
MAJOR DUTIES AND RESONSIBILITIES:
Coordinates project design, cost estimates, schedule, interface with client, etc. on capital projects.
Manages project implementation including oversight of selected vendors.
Determines specific customer and stakeholder requirements and manages communication across organizational and functional boundaries to assure that customers, peers, and support groups have a good understanding of the scope and deliverables for assigned projects.
Contribute to a high performance culture by recognizing and resolving issues as they arise.
Assures that all assigned projects comply with budgetary, regulatory, department, safety and company standards.
Support and assist Lead Project Manager on capital projects.
CONTACTS
Work with all departments and with all levels of the organization, and with contract vendors engaged in design and construction. Occasional interactions with local and state officials relating to permitting and inspections.
WORKING CONDITIONS
Work within the various environments under construction, which requires one to give a high attention to detail and to properly use the appropriate Personal Protective Equipment (PPE).
DECISION MAKING
Identifies and reports any discrepancies from normal practices or procedures to senior management, recommending and implementing corrective actions. Works on problems of diverse scope in which analysis of situation or data requires evaluation of identifiable factors. Exercises judgment in generally defined practices and policies in selecting methods and techniques for obtaining solutions. Erroneous decisions or failure to achieve goals results in additional costs and personnel, and serious delays in overall schedules.
SUPERVISION RECEIVED
Receives assignments in the form of objectives and establishes goals to meet objectives. Work is reviewed and measured based on meeting established objectives and schedules.
SUPERVISION EXERCISED
None within BMS, however there is considerable management of contract vendors in assuring desired outcomes are achieved.
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.